1. Template and target-site recognition by human LINE-1 in retrotransposition.
- Author
-
Thawani A, Ariza AJF, Nogales E, and Collins K
- Subjects
- Humans, Cryoelectron Microscopy, Catalytic Domain, Endonucleases chemistry, Endonucleases metabolism, Endonucleases ultrastructure, Genetic Therapy, RNA-Directed DNA Polymerase chemistry, RNA-Directed DNA Polymerase metabolism, RNA-Directed DNA Polymerase ultrastructure, DNA, Single-Stranded metabolism, DNA Breaks, DNA, Complementary biosynthesis, DNA, Complementary genetics, Long Interspersed Nucleotide Elements genetics, Retroelements genetics, RNA chemistry, RNA genetics, RNA metabolism, Reverse Transcription
- Abstract
The long interspersed element-1 (LINE-1, hereafter L1) retrotransposon has generated nearly one-third of the human genome and serves as an active source of genetic diversity and human disease
1 . L1 spreads through a mechanism termed target-primed reverse transcription, in which the encoded enzyme (ORF2p) nicks the target DNA to prime reverse transcription of its own or non-self RNAs2 . Here we purified full-length L1 ORF2p and biochemically reconstituted robust target-primed reverse transcription with template RNA and target-site DNA. We report cryo-electron microscopy structures of the complete human L1 ORF2p bound to structured template RNAs and initiating cDNA synthesis. The template polyadenosine tract is recognized in a sequence-specific manner by five distinct domains. Among them, an RNA-binding domain bends the template backbone to allow engagement of an RNA hairpin stem with the L1 ORF2p C-terminal segment. Moreover, structure and biochemical reconstitutions demonstrate an unexpected target-site requirement: L1 ORF2p relies on upstream single-stranded DNA to position the adjacent duplex in the endonuclease active site for nicking of the longer DNA strand, with a single nick generating a staggered DNA break. Our research provides insights into the mechanism of ongoing transposition in the human genome and informs the engineering of retrotransposon proteins for gene therapy., (© 2023. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF